Journal Article

Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic

Mahmud, Nadim, Serper, Marina, Kaplan, David E., Taddei, Tamar H., Tapper, Elliot B.

2023

Overview

We studied longitudinal trends in mortality, outpatient, and inpatient care for cirrhosis in a national cohort in the first 2 years of the coronavirus disease-2019 pandemic. We evaluated trends in hepatocellular carcinoma (HCC) surveillance and factors associated with completion. Within the national cirrhosis cohort in the Veterans Administration from 2020 to 2021, we captured mortality, outpatient primary care provider, gastroenterology/hepatology (GI/HEP) visits, and hospitalizations. HCC surveillance was computed as percentage of time up to date with surveillance every 6 months (PTUDS). Multivariable models for PTUDS were adjusted for patient demographics, clinical factors, and facility-level variables. The total cohort was 68,073; 28,678 were eligible for HCC surveillance. Outpatient primary care provider and GI/HEP appointment rates initially dropped from 30% to 7% with a rebound 1 year into the pandemic and steady subsequent use. Telemedicine monthly visit rates rose from less than 10% to a peak of 20% with a steady gradual decline. Nearly 70% of Veterans were up to date with HCC surveillance before the pandemic with an early pandemic nadir of approximately 50% and 60% PTUDS 2 years into the pandemic. In adjusted models, use of a population-based cirrhosis dashboard (β 8.5, 95% CI 6.9-10.2) and GI/HEP visits both in-person (β 3.2, 95% CI 2.9-3.6) and telemedicine (β 2.1, 95% CI 1.9-2.4) were associated with a higher PTUDS. Outpatient utilization and HCC surveillance rates have rebounded but remain below at baseline. Population-based approaches and specialty care for cirrhosis were associated with a higher completion of HCC surveillance.

• Publisher: Wolters Kluwer,Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• Subject: Abdomen / Carcinoma, Hepatocellular - complications / Carcinoma, Hepatocellular - epidemiology / Carcinoma, Hepatocellular - therapy / Cardiovascular disease / Coronaviruses / COVID-19 / COVID-19 - complications / COVID-19 - epidemiology / Gastroenterology / Health services utilization / Hepatology / Hospitalization / Humans / Liver cancer / Liver cirrhosis / Liver Cirrhosis - complications / Liver Cirrhosis - epidemiology / Liver diseases / Liver Neoplasms - complications / Liver Neoplasms - epidemiology / Liver Neoplasms - therapy / Medical records / Pandemics / Patients / Regression analysis / Telemedicine / Transplants & implants / Trends / Ultrasonic imaging / Variables